MustGrow Announces Investor Relations Agreement with Harbor Access
13 September 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”) is pleased to announce the
Read More
MustGrow
MustGrow and Janssen PMP, a division of Janssen Pharmaceutica NV, Announce Significant Project Expansion
07 September 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”), and Janssen PMP, a division
Read More
MustGrow Announces Grant of RSUs and DSUs
05 September 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”), today announced that the
Read More
MustGrow Wins “AgTech Innovation Of The Year” Award From AgTech Breakthrough
18 August 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO; OTC: MGROF; FRA: 0C0) (“MustGrow”), an agricultural biotechnology company focused on providing science-based
Read More
MustGrow Completes Initial Commercial Production Run via Contract Manufacturer
13 June 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”), is pleased to announce
Read More
MustGrow and Bio Ag Product Strategies Sign Agreement to Develop and Commercialize Soil Amendment & Biofertility Technologies
06 June 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”), is pleased to announce the signing
Read More
MustGrow and Janssen PMP, a division of Janssen Pharmaceutica NV, extend exclusive global partnership
24 May 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company“, “MustGrow“), and JANSSEN PMP, a division of Janssen Pharmaceutica NV,
Read More
MustGrow Announces Soil Amendment and Biofertility Programs for Sustainable Agriculture
18 April 2023, Canada: MustGrow Biologics Corp., is pleased to report an additional area of sustainable agriculture opportunity that the Company
Read More
MustGrow Reports Growth of Global Patent Portfolio
09 March 2023, Canada: MustGrow Biologics Corp., is pleased to report on the growth of its intellectual property portfolio (the “IP Portfolio”)
Read More
MustGrow Receives Final Approval to List on the TSX Venture Exchange
10 November 2022, Canada: MustGrow Biologics Corp. (CSE: MGRO; OTCQB: MGROF; FRA: 0C0) (the “Company” or “MustGrow”), is pleased to announce that the TSX
Read More